je.st
news
GSK wins priority status for new HIV drug in U.S
2013-02-15 19:10:30| Biotech - Topix.net
U.S. regulators gave priority review status to an experimental GlaxoSmithKline drug for HIV/AIDS, which industry analysts view as a possible multibillion-dollar-a-year seller.
Tags: us
status
drug
priority
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||